OSTERTAG ERIC (Chief Executive Officer) sold 10.0% of their position (20K shares) of POSEIDA THERAPEUTICS, INC. on the open market
Open‑market sale worth $162.7K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
Common Stock
Shares
+2.76K
Price / share
$1.17
Trade value
$3.23K
% of position
Common Stock
Shares
+18.52K
Price / share
$9.15
Trade value
$169.49K
% of position
Common Stock
Shares
−20K
Price / share
$8.14
Trade value
$162.71K
% of position
Net shares
+1.28K
Net value
$10.02K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 9/13/2021 | M · Option Exercise | +2.76K | $1.17 | $3.23K | 0.4% | 654.13K | 656.89K |
| Common Stock Direct | 9/13/2021 | M · Option Exercise | +18.52K | $9.15 | $169.49K | 2.8% | 656.89K | 675.41K |
| Common Stock Indirect | 9/14/2021 | S · Sale | −20K | $8.14 | $162.71K | 10.0% | 200.70K | 180.70K |
| Total | +1.28K | $10.02K | ||||||
Employee Stock Option (Right to Buy)
Common Stock
2.76K shares
Shares
−2.76K
Strike price
1.173
Held after
0.00
Exercisable
—
Employee Stock Option (Right to Buy)
Common Stock
18.52K shares
Shares
−18.52K
Strike price
9.15
Held after
759.52K
Exercisable
—
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Employee Stock Option (Right to Buy) Direct | Common Stock2.76K shares | 9/13/2021 | M · Option Exercise | −2.76K | 1.173 | — | 0.00 |
| Employee Stock Option (Right to Buy) Direct | Common Stock18.52K shares | 9/13/2021 | M · Option Exercise | −18.52K | 9.15 | — | 759.52K |
Common Stock
IndirectCommon Stock
IndirectCommon Stock
IndirectCommon Stock
Indirect| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 629.19K | Indirect |
| Common Stock | 3.38M | Indirect |
| Common Stock | 961.45K | Indirect |
| Common Stock | 3.68M | Indirect |
| Total | 8.65M | 8.65M indirect |